exchange efficiency and stability of bispecific antibodies
Sheathless CE-MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies
Bispecific monoclonal antibodies (BsAbs) are receiving great attention due to their extensive benefits as biopharmaceuticals and their involvement in IgG4 mediated autoimmune diseases. While the production of BsAbs is getting more accessible, their analytical characterization remains challenging.
We explored the potential of sheathless CE-MS for monitoring exchange efficiency and stability of in-house produced bispecific antibodies. Two IgG4 bispecific antibodies with different molecular characteristics were prepared using controlled Fab (Fragment antigen binding) -arm exchange. Separation of BsAbs from their parent monospecific antibodies was achieved using a PEI-coated capillary and acidic background electrolytes permitting reliable assessment of the exchange efficiency.
This was especially valuable for a Fab-glycosylated BsAb where the high glycan heterogeneity resulted in an overlap of masses with the monospecific parent antibody, hindering their discrimination by MS only.
The method showed also good capabilities to monitor the stability of the generated BsAbs under different storage conditions. The levels of degradation products were different for the studied antibodies indicating pronounced differences in stability. Overall, the proposed method represents a useful analytical tool for exchange efficiency and stability studies of bispecific antibodies. This article is protected by copyright. All rights reserved.
enviroshieldproducts
) human anti-human IL-8 mAb (AB) |
|||
| E4A09D07-C8A | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
 Human IL-8 Antibody |
|||
| 33486-05111 | AssayPro | 150 ug | EUR 313.2 |
 Human IL-8 |
|||
| 90258-A | BPS Bioscience | 5 µg | EUR 130 |
|
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli. |
|||
Human IL-8 |
|||
| 90258-B | BPS Bioscience | 25 µg | EUR 205 |
|
Description: Recombinant human Interleukin-8 is a disulfide-linked monomer protein consisting of 78 amino acid residues, migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Interleukin-8 mature chain was expressed in E. coli. |
|||
 Antibody) Human Interleukin-8 (IL-8) Antibody |
|||
| 13102-05011 | AssayPro | 150 ug | EUR 248.4 |
) Anti-CXCL8 / IL-8 Reference Antibody (Genentech anti-IL-8) |
|||
| E24CHA784 | EnoGene | 100 μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
 Anti-IL-8 Antibody |
|||
| A2062-100 | Biovision | 100 µg | EUR 472.8 |
Anti-IL-8 Antibody |
|||
| A00423 | BosterBio | 1 mL | EUR 1444.8 |
|
Description: Rabbit Polyclonal IL-8 Antibody. Validated in IP, WB and tested in Human. |
|||
 Anti-IL-8 antibody |
|||
| STJ97710 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ97717 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ97720 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Mouse monoclonal to IL-8. |
|||
Anti-IL-8 antibody |
|||
| STJ98175 | St John's Laboratory | 100 µl | EUR 280.8 |
|
Description: Mouse monoclonal to IL-8. |
|||
) anti-IL-8 (3E4D8) |
|||
| LF-MA30011 | Abfrontier | 100 ul | EUR 448.8 |
|
Description: Mouse Monoclonal to IL-8 |
|||
) human-anti-human-IL-8-mAb(1H) |
|||
| E409C16-hA100 | EnoGene | Inflammation-Storm-Antibodies | EUR 276.5 |
|
Description: Inflammation Storm Antibodies |
|||
) human-anti-human-IL-8-mAb(2H) |
|||
| E409C16-hB100 | EnoGene | Inflammation-Storm-Antibodies | EUR 276.5 |
|
Description: Inflammation Storm Antibodies |
|||
 IL-8/CXCL8, Human |
|||
| HY-P7224 | MedChemExpress | 50ug | EUR 596.4 |
 Human IL-8 Protein |
|||
| abx060803-25ug | Abbexa | 25 ug | EUR 644.4 |
Human IL-8 Protein |
|||
| abx060804-25ug | Abbexa | 25 ug | EUR 644.4 |
 Recombinant Human IL-8 |
|||
| P0180 | FN Test | 100ug | EUR 626.83 |
|
Description: Recombinant Human protein for IL-8 |
|||
Recombinant Human IL-8 |
|||
| SJB05-01 | Amyotop | 25µg/vial | EUR 342 |
 mAb mouse anti-human IL-8 |
|||
| CT264 | U-CyTech | 0.5 mg | EUR 312 |
 mouse anti-human IL-8 mAb |
|||
| E409C16-m100 | EnoGene | 100μL | EUR 395 |
|
Description: Available in various conjugation types. |
|||
 Antibody (Biotin Conjugate)) Human Interleukin-8 (IL-8) Antibody (Biotin Conjugate) |
|||
| 13102-05021 | AssayPro | 150 ug | EUR 313.2 |
 Rabbit anti-IL-8 Antibody |
|||
| DL90596A-100ul | DL Develop | 100 ul | EUR 270 |
|
Description: CXCL8; Interleukin-8; IL-8; C-X-C motif chemokine 8; Emoctakin; Granulocyte chemotactic protein 1; GCP-1; Monocyte-derived neutrophil chemotactic factor; MDNCF; Monocyte-derived neutrophil-activating peptide; MONAP; Neutrophil-activating protein 1; NAP-1; Protein 3-10C; T-cell chemotactic factor |
|||
Rabbit anti-IL-8 Antibody |
|||
| DL90596A-50ul | DL Develop | 50 ul | EUR 189 |
|
Description: CXCL8; Interleukin-8; IL-8; C-X-C motif chemokine 8; Emoctakin; Granulocyte chemotactic protein 1; GCP-1; Monocyte-derived neutrophil chemotactic factor; MDNCF; Monocyte-derived neutrophil-activating peptide; MONAP; Neutrophil-activating protein 1; NAP-1; Protein 3-10C; T-cell chemotactic factor |
|||
Rabbit anti-IL-8 Antibody |
|||
| YLD4345-100ul | Shanghai YL Biotech | 100 ul | EUR 320 |
|
Description: Rabbit polyclonal antibody to IL-8 |
|||
Rabbit anti-IL-8 Antibody |
|||
| YLD4345-50ul | Shanghai YL Biotech | 50 ul | EUR 200 |
|
Description: Rabbit polyclonal antibody to IL-8 |
|||
 Human IL-8 ELISA antibody pair |
|||
| CT748-10 | U-CyTech | 10-plate | EUR 656.4 |
Human IL-8 ELISA antibody pair |
|||
| CT748-20 | U-CyTech | 20-plate | EUR 1118.4 |
 Anti-IL-8 Monoclonal Antibody |
|||
| A00423-1 | BosterBio | 100ul | EUR 476.4 |
|
Description: Mouse Monoclonal Antibody for IL-8 Antibody (CXCL8) detection. Tested with IHC in Human, Mouse, Rat. |
|||
 CLIA Kit) Human Interleukin 8 (IL-8) CLIA Kit |
|||
| abx195916-96tests | Abbexa | 96 tests | EUR 990 |
 Human Interleukin 8,IL-8 ELISA KIT |
|||
| 201-12-0090 | SunredBio | 96 tests | EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
 Human Interleukin 8, IL-8 ELISA KIT |
|||
| CSB-E04641h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid (CSF), tissue homogenates, cell lysates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Interleukin 8, IL-8 ELISA KIT |
|||
| 1-CSB-E04641h | Cusabio |
|
|
|
Description: Quantitative sandwich ELISA kit for measuring Human Interleukin 8, IL-8 in samples from serum, cell culture supernates, saliva, urine, cerebrospinalfluid(CSF), tissue homogenates, cell lysates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
ELISA Kit) Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human Interleukin 8(IL-8)ELISA Kit |
|||
| GA-E0129HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
 ELISA Kit) Human IL-8(Interleukin 8) ELISA Kit |
|||
| EH0205 | FN Test | 96T | EUR 571.5 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
|||
Human Interleukin 8(IL-8)ELISA Kit |
|||
| QY-E04259 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human Interleukin 8,IL-8 ELISA KIT |
|||
| YLA1210HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
Human IL-8(Interleukin 8) ELISA Kit |
|||
| E39EH0205 | EnoGene | 96T | EUR 595 |
 ELISA Kit) Human Interleukin-8 (IL-8) ELISA Kit |
|||
| LF-EK60006 | Abfrontier | 1×96T | EUR 948 |
) Human IL-8 Antibody (Biotin Conjugate) |
|||
| 33486-05121 | AssayPro | 150 ug | EUR 442.8 |
， Human) IL-8 (72 a.a.)， Human |
|||
| E34M010H | EnoGene | 5 μg | EUR 155 |
|
Description: Recombinant Human Cytotoxic T-lymphocyte Protein 4 is produced by our Mammalian expression system and the target gene encoding Lys36-Asp161 is expressed with a Flag tag at the C-terminus. |
|||
 human IL-8 His tag |
|||
| E410A07-100 | EnoGene | 100μg | EUR 1152 |
 Human IL-8 ELISA kit |
|||
| CT212A | U-CyTech | 5-plate | EUR 554.4 |
Human IL-8 ELISA kit |
|||
| LF-EK50165 | Abfrontier | 1×96T | EUR 777.6 |
 IL-8 ELISA KIT|Human |
|||
| EF003990 | Lifescience Market | 96 Tests | EUR 826.8 |
 Human IL-8 ELISA Kit |
|||
| EHI0063 | Abclonal | 96Tests | EUR 625.2 |
 IL-8/CXCL8, 72a.a., Human |
|||
| HY-P7380 | MedChemExpress | 50ug | EUR 596.4 |
 ELISA Kit) IL-8 (Human) ELISA Kit |
|||
| K4169-100 | Biovision | each | EUR 874.8 |
Human IL-8 ELISA Kit |
|||
| E28L0023 | EnoGene | 96T | EUR 666.67 |
 Human IL-8 ELISA KIT |
|||
| E42EH-07 | EnoGene | 96T/48T | Ask for price |
Human IL-8 ELISA Kit |
|||
| E16HE0011 | EnoGene | 96T | EUR 733.33 |
Human IL-8 ELISA KIT |
|||
| E16HE0011-048 | EnoGene | 48 wells | EUR 295 |
Human IL-8 ELISA KIT |
|||
| E16HE0011-096 | EnoGene | 96 wells | EUR 395 |
Human IL-8 ELISA kit |
|||
| E22-HC008.48 | EnoGene | 48T | EUR 295 |
Human IL-8 ELISA kit |
|||
| E22-HC008.96 | EnoGene | 96T | EUR 395 |
) rec Monocyte IL-8 (human) |
|||
| H-9625.0005 | Bachem | 5.0µg | EUR 194.4 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
rec Monocyte IL-8 (human) |
|||
| H-9625.0025 | Bachem | 25.0µg | EUR 457.2 |
|
Description: Sum Formula: C372H600N106O106S4; CAS# [142298-00-8] |
|||
) rec Endothelial IL-8 (human) |
|||
| H-3742.0010 | Bachem | 10.0µg | EUR 340.8 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
rec Endothelial IL-8 (human) |
|||
| H-3742.0050 | Bachem | 50.0µg | EUR 1167.6 |
|
Description: Sum Formula: C397H644N114O111S4; CAS# [142298-01-9] |
|||
) Recombinant Human IL-8 (72a.a.) |
|||
| HEILP-0801 | Cyagen | 5ug | Ask for price |
) Recombinant Human IL-8 (77a.a.) |
|||
| HEILP-0802 | Cyagen | 5ug | Ask for price |
 AssayLite Antibody (RPE Conjugate)) Human Interleukin-8 (IL-8) AssayLite Antibody (RPE Conjugate) |
|||
| 13102-05051 | AssayPro | 150 ug | EUR 513.6 |
 AssayLite Antibody (APC Conjugate)) Human Interleukin-8 (IL-8) AssayLite Antibody (APC Conjugate) |
|||
| 13102-05061 | AssayPro | 150 ug | EUR 513.6 |
 AssayLite Antibody (FITC Conjugate)) Human Interleukin-8 (IL-8) AssayLite Antibody (FITC Conjugate) |
|||
| 13102-05041 | AssayPro | 150 ug | EUR 513.6 |
 AssayLite Antibody (PerCP Conjugate)) Human Interleukin-8 (IL-8) AssayLite Antibody (PerCP Conjugate) |
|||
| 13102-05071 | AssayPro | 150 ug | EUR 565.2 |
Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
An effective vaccine is essential for controlling the spread of the SARS-CoV-2 virus. Here, we describe an influenza virus-based vaccine for SARS-CoV-2. We incorporated a membrane-anchored form of the SARS-CoV-2 spike receptor binding domain (RBD) in place of the neuraminidase (NA) coding sequence in an influenza virus also possessing a mutation that reduces the affinity of hemagglutinin for its sialic acid receptor.
The resulting ΔNA(RBD)-Flu virus can be generated by reverse genetics and grown to high titers in cell culture. A single-dose intranasal inoculation of mice with ΔNA(RBD)-Flu elicits serum neutralizing antibody titers against SAR-CoV-2 comparable to those observed in humans following natural infection (~1:200).
Furthermore, NA(RBD)-FΔlu itself causes no apparent disease in mice. It might be possible to produce a vaccine similar to ΔNA(RBD)-Flu at scale by leveraging existing platforms for the production of influenza vaccines.
Human monoclonal anti‑TLR4 antibody negatively regulates lipopolysaccharide‑induced inflammatory responses in mouse macrophages
- Previous studies have revealed that activation of the Toll‑like receptor 4 (TLR4)‑mediated proinflammatory signaling pathway plays an important role in acute inflammation, sepsis and chronic inflammatory disorders.
- Moreover, TLR4 significantly contributes to lipopolysaccharide (LPS)‑induced immune response. Thus, modulation of the TLR4 pathway is an important strategy to specifically target these pathologies.
- The aim of the present study was to develop a complete human anti‑TLR4 IgG2 antibody by screening human TLR4 Fab from a phage‑display library and integrating it with constant regions of the heavy chain of human IgG2 via antibody engineering. ELISA, a BLItz system and fluorescence‑activated cell sorting were used to assess its affinity.
- Furthermore, mouse‑derived peritoneal macrophages were treated with human anti‑TLR4 IgG2 and induced with LPS in vitro. Reverse transcription‑quantitative PCR and western blotting were used to determine mRNA expression levels of cytokines and phosphorylation levels of signaling pathways, respectively.
- It was found that human anti‑TLR4 IgG2 bound to TLR4 with a high affinity of 8.713×10‑10 M, and that preincubation with anti‑TLR4 IgG2 inhibited the LPS‑induced production of tumor necrosis factor‑α, interferon‑β and interleukin‑6 mRNA expression levels in mouse peritoneal macrophages.
- It was also demonstrated that human anti‑TLR4 IgG2 inhibited LPS‑induced TLR4 signaling by reducing the phosphorylation of the NF‑κB, mitogen‑activated protein kinase and interferon regulatory factor 3 signaling pathways.
- In addition, human anti‑TLR4 IgG2 protected mice from LPS challenge with a survival rate of 40% and also significantly increased the survival time in the cecal ligation and puncture model. Therefore, it was speculated that human anti‑TLR4 IgG2 plays a protective role against sepsis‑associated injury and is potentially applicable for the treatment of infection‑associated immune dysfunction.
) PE anti-human CD158d (KIR2DL4) |
|||
| E16FHP158d-100 | EnoGene | 100 tests | EUR 1278.33 |
|
Description: Available in various conjugation types. |
|||
 KIR2DL4 |
|||
| pro-2460 | ProSpec Tany | 1µg | EUR 60 |
|
Description: Recombinant Human Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 4 |
|||
) APC anti-human CD158d (KIR2DL4) |
|||
| E16FHA158d-025 | EnoGene | 25 tests | EUR 563.33 |
|
Description: Available in various conjugation types. |
|||
APC anti-human CD158d (KIR2DL4) |
|||
| E16FHA158d-100 | EnoGene | 100 tests | EUR 1321.67 |
|
Description: Available in various conjugation types. |
|||
 Human KIR2DL4 ELISA KIT |
|||
| ELI-21303h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR2DL4 shRNA Plasmid |
|||
| 20-abx952576 | Abbexa |
|
|
 KIR2DL4 antibody |
|||
| 70R-2365 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal KIR2DL4 antibody raised against the middle region of KIR2DL4 |
|||
 KIR2DL4 Antibody |
|||
| E309374 | EnoGene | 200ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
KIR2DL4 Antibody |
|||
| DF13591 | Affinity Biosciences | 100ul | EUR 280 |
|
Description: Human,Rat |
|||
KIR2DL4 Antibody |
|||
| E912836 | EnoGene | 100ul | EUR 255 |
|
Description: Available in various conjugation types. |
|||
KIR2DL4 Antibody |
|||
| DF13591-100ul | Affinity Biosciences | 100ul | EUR 280 |
KIR2DL4 Antibody |
|||
| DF13591-200ul | Affinity Biosciences | 200ul | EUR 350 |
 Human KIR2DL4 Protein, Fc Tag |
|||
| E40KMPH4155 | EnoGene | 20ug | EUR 495 |
Human KIR2DL4 Protein, Fc Tag |
|||
| E40KMPH4156 | EnoGene | 20ug | EUR 495 |
) KIR2DL4 Recombinant Protein (Human) |
|||
| RP017041 | ABM | 100 ug | Ask for price |
) NE Purified anti-human CD158d (KIR2DL4) |
|||
| E16FHY158d-050U | EnoGene | 50 μg | EUR 845 |
|
Description: Available in various conjugation types. |
|||
 (pORF)) KIR2DL4 ORF Vector (Human) (pORF) |
|||
| ORF005681 | ABM | 1.0 ug DNA | EUR 114 |
 KIR2DL4 siRNA |
|||
| 20-abx921662 | Abbexa |
|
|
 Human KIR2DL4 Protein Lysate 20ug |
|||
| IHUKIR2DL4PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR2DL4 Protein Lysate 20ug |
|||
 KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
| 20-abx210854 | Abbexa |
|
|
KIR2DL3 / KIR2DL1 / KIR2DL4 / KIR2DS4 Antibody |
|||
| 20-abx339417 | Abbexa |
|
|
 KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
| 1-CSB-PA205578 | Cusabio |
|
|
|
Description: A polyclonal antibody against KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4. Recognizes KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
|||
KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 Antibody |
|||
| 1-CSB-PA246816 | Cusabio |
|
|
|
Description: A polyclonal antibody against KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4. Recognizes KIR2DL3/KIR2DL1/KIR2DL4/KIR2DS4 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:50-1:100 |
|||
 KIR2DL4 Polyclonal Antibody |
|||
| 27806-100ul | SAB | 100ul | EUR 302.4 |
KIR2DL4 Polyclonal Antibody |
|||
| 27806-50ul | SAB | 50ul | EUR 224.4 |
 KIR2DL4 Rabbit pAb |
|||
| A12836-100ul | Abclonal | 100 ul | EUR 369.6 |
KIR2DL4 Rabbit pAb |
|||
| A12836-200ul | Abclonal | 200 ul | EUR 550.8 |
KIR2DL4 Rabbit pAb |
|||
| A12836-20ul | Abclonal | 20 ul | EUR 219.6 |
KIR2DL4 Rabbit pAb |
|||
| A12836-50ul | Abclonal | 50 ul | EUR 267.6 |
KIR2DL4 Rabbit pAb |
|||
| E2511314 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
 Recombinant Human KIR2DL4 Protein, His Tag |
|||
| E40KMH1307 | EnoGene | 20ug | EUR 495 |
) Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
| C310-10ug | Novoprotein | 10ug | EUR 157.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
| C310-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
| C310-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
Recombinant Human KIR2DL4/CD158d/KIR103 (C-6His) |
|||
| C310-50ug | Novoprotein | 50ug | EUR 327.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4. |
|||
) KIR2DL4 sgRNA CRISPR Lentivector set (Human) |
|||
| K1150301 | ABM | 3 x 1.0 ug | EUR 406.8 |
 KIR2DL4 cloning plasmid |
|||
| CSB-CL857457HU-10ug | Cusabio | 10ug | EUR 279.6 |
|
Description: A cloning plasmid for the KIR2DL4 gene. |
|||
 KIR2DL4 Blocking Peptide |
|||
| 33R-9831 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIR2DL4 antibody, catalog no. 70R-2365 |
|||
 (pPM-C-HA)) KIR2DL4 Protein Vector (Human) (pPM-C-HA) |
|||
| PV022723 | ABM | 500 ng | EUR 394.8 |
 KIR2DL4 Recombinant Protein |
|||
| 91-290 | ProSci | 0.05 mg | EUR 556.8 |
|
Description: Killer cell immunoglobulin-like receptor 2DL4(KIR2DL4) is a Single-pass type I membrane protein and contains 2 Ig-like C2-type (immunoglobulin-like) domains.It belongs to the immunoglobulin superfamily. KIR2DL4 is expressed in all NK cells and some T cells. KIR2DL4 activates the cytotoxicity of NK cells, despite the presence of an immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic tail. The ITIM was not necessary for activation of lysis by KIR2DL4. The activation signal of KIR2DL4 was sensitive to inhibition by another ITIM-containing receptor. The activation-deficient mutant of KIR2DL4 inhibited the signal delivered by the activating receptor CD16. |
|||
 (pPB-C-His)) KIR2DL4 Protein Vector (Human) (pPB-C-His) |
|||
| PV022721 | ABM | 500 ng | EUR 394.8 |
 (pPB-N-His)) KIR2DL4 Protein Vector (Human) (pPB-N-His) |
|||
| PV022722 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-His)) KIR2DL4 Protein Vector (Human) (pPM-C-His) |
|||
| PV022724 | ABM | 500 ng | EUR 394.8 |
 KIR2DL4 Polyclonal Conjugated Antibody |
|||
| C27806 | SAB | 100ul | EUR 476.4 |
 Recombinant Human KIR2DL4 Protein, His, Insect-1ug |
|||
| QP12489-1ug | EnQuireBio | 1ug | EUR 186 |
 Recombinant Human KIR2DL4 Protein, His, Insect-5ug |
|||
| QP12489-5ug | EnQuireBio | 5ug | EUR 241.2 |
 Recombinant Human KIR2DL4 Protein, His, Insect-50ug |
|||
| QP12489-50ug | EnQuireBio | 50ug | EUR 1513.2 |
 (Target 1)) KIR2DL4 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K1150302 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 2)) KIR2DL4 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K1150303 | ABM | 1.0 ug DNA | EUR 184.8 |
 (Target 3)) KIR2DL4 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K1150304 | ABM | 1.0 ug DNA | EUR 184.8 |
 Recombinant Human CD158D/KIR2DL4 Protein, His Tag |
|||
| E40KMH335 | EnoGene | 20ug | EUR 495 |
 Human KIR2DL4 Recombinant Protein C-6 His Tag Lyophilized |
|||
| IHUKIR2DL4RC6HISLY50UG | Innovative research | each | EUR 640 |
|
Description: Human KIR2DL4 Recombinant Protein C-6 His Tag Lyophilized |
|||
) KIR2DL4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K1150305 | ABM | 3 x 1.0 ug | EUR 451.2 |
 KIR2DL4 3'UTR GFP Stable Cell Line |
|||
| TU061796 | ABM | 1.0 ml | EUR 1825.2 |
 KIR2DL4 3'UTR Luciferase Stable Cell Line |
|||
| TU011796 | ABM | 1.0 ml | EUR 1825.2 |
 (Target 1)) KIR2DL4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K1150306 | ABM | 1.0 ug DNA | EUR 200.4 |
 (Target 2)) KIR2DL4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K1150307 | ABM | 1.0 ug DNA | EUR 200.4 |
 (Target 3)) KIR2DL4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K1150308 | ABM | 1.0 ug DNA | EUR 200.4 |
 Antibody) Killer Cell Immunoglobulin-Like Receptor 2DL4 (KIR2DL4) Antibody |
|||
| abx145740-100ug | Abbexa | 100 ug | EUR 469.2 |
 (Western Blot)) Rabbit Anti KIR2DL4 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Western Blot) |
|||
| IRBAMLKIR2DL4AP343120UL | Innovative research | each | EUR 346 |
|
Description: Rabbit Anti KIR2DL4 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Western Blot) |
|||
Rabbit Anti KIR2DL4 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Western Blot) |
|||
| IRBAMLKIR2DL4AP343200UL | Innovative research | each | EUR 509 |
|
Description: Rabbit Anti KIR2DL4 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Western Blot) |
|||
 Human KIR2DL3 Antibody |
|||
| 32965-05111 | AssayPro | 150 ug | EUR 313.2 |
) PE anti-human CD158f (KIR2DL5) |
|||
| E16FHP158f-025 | EnoGene | 25 tests | EUR 541.67 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158f (KIR2DL5) |
|||
| E16FHP158f-100 | EnoGene | 100 tests | EUR 1256.67 |
|
Description: Available in various conjugation types. |
|||
 KIR2DL4 Killer Cell Immunoglobulin-Like Receptor, 2 Domains Long Cytoplasmic Tail 4 Human Recombinant Protein |
|||
| PROTQ99706 | BosterBio | Regular: 5ug | EUR 380.4 |
|
Description: KIR2DL4 Human Recombinant produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 458 amino acids (24-242 a.a.) and having a molecular mass of 51kDa (Molecular size on SDS-PAGE will appear at approximately 50-70kDa). KIR2DL4 is expressed with a 239 amino acids hIgG-His tag at C-Terminus and purified by proprietary chromatographic techniques. |
|||
) PE anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHP158e-025 | EnoGene | 25 tests | EUR 433.33 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHP158e-100 | EnoGene | 100 tests | EUR 953.33 |
|
Description: Available in various conjugation types. |
|||
 anti- KIR2DL3 antibody |
|||
| FNab04581 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against KIR2DL3 |
|||
 anti- KIR3DL1 antibody |
|||
| FNab04583 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against KIR3DL1 |
|||
) PE anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHP158-025 | EnoGene | 25 tests | EUR 520 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHP158-100 | EnoGene | 100 tests | EUR 1083.33 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHP158a-025 | EnoGene | 25 tests | EUR 520 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHP158a-100 | EnoGene | 100 tests | EUR 1083.33 |
|
Description: Available in various conjugation types. |
|||
) APC anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHA158e-025 | EnoGene | 25 tests | EUR 411.67 |
|
Description: Available in various conjugation types. |
|||
APC anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHA158e-100 | EnoGene | 100 tests | EUR 1105 |
|
Description: Available in various conjugation types. |
|||
) APC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHA158a-025 | EnoGene | 25 tests | EUR 455 |
|
Description: Available in various conjugation types. |
|||
APC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHA158a-100 | EnoGene | 100 tests | EUR 1191.67 |
|
Description: Available in various conjugation types. |
|||
) FITC anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHF158e-025 | EnoGene | 25 tests | EUR 368.33 |
|
Description: Available in various conjugation types. |
|||
FITC anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHF158e-100 | EnoGene | 100 tests | EUR 845 |
|
Description: Available in various conjugation types. |
|||
) PE anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHP158b-025 | EnoGene | 25 tests | EUR 433.33 |
|
Description: Available in various conjugation types. |
|||
PE anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHP158b-100 | EnoGene | 100 tests | EUR 953.33 |
|
Description: Available in various conjugation types. |
|||
) FITC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHF158-025 | EnoGene | 25 tests | EUR 368.33 |
|
Description: Available in various conjugation types. |
|||
FITC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHF158-100 | EnoGene | 100 tests | EUR 845 |
|
Description: Available in various conjugation types. |
|||
FITC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHF158a-025 | EnoGene | 25 tests | EUR 368.33 |
|
Description: Available in various conjugation types. |
|||
FITC anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHF158a-100 | EnoGene | 100 tests | EUR 845 |
|
Description: Available in various conjugation types. |
|||
) APC anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHA158b-025 | EnoGene | 25 tests | EUR 520 |
|
Description: Available in various conjugation types. |
|||
APC anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHA158b-100 | EnoGene | 100 tests | EUR 1040 |
|
Description: Available in various conjugation types. |
|||
) Biotin anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHB158e-100U | EnoGene | 100 μg | EUR 780 |
|
Description: Available in various conjugation types. |
|||
) FITC anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHF158b-025 | EnoGene | 25 tests | EUR 368.33 |
|
Description: Available in various conjugation types. |
|||
FITC anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHF158b-100 | EnoGene | 100 tests | EUR 845 |
|
Description: Available in various conjugation types. |
|||
 Human KIR2DL1 ELISA KIT |
|||
| ELI-47905h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR3DL2 ELISA KIT |
|||
| ELI-47907h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR3DL3 ELISA KIT |
|||
| ELI-47908h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR2DL2 ELISA KIT |
|||
| ELI-23746h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR3DL1 ELISA KIT |
|||
| ELI-23748h | Lifescience Market | 96 Tests | EUR 988.8 |
) PE-Cy7 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHN158e-025 | EnoGene | 25 tests | EUR 650 |
|
Description: Available in various conjugation types. |
|||
PE-Cy7 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHN158e-100 | EnoGene | 100 tests | EUR 1408.33 |
|
Description: Available in various conjugation types. |
|||
) PE-Cy7 anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHN158a-025 | EnoGene | 25 tests | EUR 455 |
|
Description: Available in various conjugation types. |
|||
PE-Cy7 anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHN158a-100 | EnoGene | 100 tests | EUR 1191.67 |
|
Description: Available in various conjugation types. |
|||
 Human KIR2DL5A ELISA KIT |
|||
| ELI-08129h | Lifescience Market | 96 Tests | EUR 988.8 |
 Human KIR2DL5B ELISA KIT |
|||
| ELI-14141h | Lifescience Market | 96 Tests | EUR 988.8 |
) Purified anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHU158-100U | EnoGene | 100 μg | EUR 411.67 |
|
Description: Available in various conjugation types. |
|||
 Human KIR3DL2 / CD158k, Fc Tag |
|||
| E24PHA171 | EnoGene | 50 μg | EUR 180 |
 KIR2DL3 ELISA KIT|Human |
|||
| EF010535 | Lifescience Market | 96 Tests | EUR 826.8 |
 KIR3DL1 ELISA KIT|Human |
|||
| EF010537 | Lifescience Market | 96 Tests | EUR 826.8 |
) Human KIR2DL3 Antibody (Biotin Conjugate) |
|||
| 32965-05121 | AssayPro | 150 ug | EUR 442.8 |
) PE-Cy7 anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHN158b-025 | EnoGene | 25 tests | EUR 541.67 |
|
Description: Available in various conjugation types. |
|||
PE-Cy7 anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHN158b-100 | EnoGene | 100 tests | EUR 1278.33 |
|
Description: Available in various conjugation types. |
|||
 Human KIR3DL2 / CD158k, His Tag |
|||
| E24PHA172 | EnoGene | 50 μg | EUR 225 |
 Human KIR2DL1 Protein, Fc Tag |
|||
| E40KMPH4199 | EnoGene | 20ug | EUR 495 |
 Human KIR2DL3 Protein, Fc Tag |
|||
| E40KMPH6220 | EnoGene | 20ug | EUR 495 |
) PerCP-Cy5.5 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHS158e-025 | EnoGene | 25 tests | EUR 650 |
|
Description: Available in various conjugation types. |
|||
PerCP-Cy5.5 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHS158e-100 | EnoGene | 100 tests | EUR 1408.33 |
|
Description: Available in various conjugation types. |
|||
) Purified anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHU158b-100U | EnoGene | 100 μg | EUR 411.67 |
|
Description: Available in various conjugation types. |
|||
) PerCP-Cy5.5 anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHS158a-025 | EnoGene | 25 tests | EUR 628.33 |
|
Description: Available in various conjugation types. |
|||
PerCP-Cy5.5 anti-human CD158 (KIR2DL1/S1/S3/S5) |
|||
| E16FHS158a-100 | EnoGene | 100 tests | EUR 1451.67 |
|
Description: Available in various conjugation types. |
|||
 Rabbit Anti-Human KIR3DL3 polyclonal antibody |
|||
| CABT-BL004 | Creative Diagnostics | 100 ul | EUR 702 |
 Human KIR2DL1 shRNA Plasmid |
|||
| 20-abx952573 | Abbexa |
|
|
 Human KIR2DL2 shRNA Plasmid |
|||
| 20-abx952574 | Abbexa |
|
|
 Human KIR2DL3 shRNA Plasmid |
|||
| 20-abx952575 | Abbexa |
|
|
 Human KIR3DL1 shRNA Plasmid |
|||
| 20-abx952580 | Abbexa |
|
|
 Human KIR3DL2 shRNA Plasmid |
|||
| 20-abx952581 | Abbexa |
|
|
 Human KIR3DL3 shRNA Plasmid |
|||
| 20-abx964456 | Abbexa |
|
|
 Human KIR2DL3 Protein, His Tag |
|||
| E40KMPH4128 | EnoGene | 20ug | EUR 495 |
|
Description: Antigen Grade |
|||
 Human KIR2DL1 Protein, His Tag |
|||
| E40KMPH4200 | EnoGene | 20ug | EUR 495 |
Human KIR2DL3 Protein, His Tag |
|||
| E40KMPH6225 | EnoGene | 20ug | EUR 495 |
 Human KIR2DL5A shRNA Plasmid |
|||
| 20-abx961411 | Abbexa |
|
|
) PerCP-Cy5.5 anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHS158b-025 | EnoGene | 25 tests | EUR 650 |
|
Description: Available in various conjugation types. |
|||
PerCP-Cy5.5 anti-human CD158b (KIR2DL2/L3, NKAT2) |
|||
| E16FHS158b-100 | EnoGene | 100 tests | EUR 1408.33 |
|
Description: Available in various conjugation types. |
|||
) Alexa Fluor® 700 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHI158e-025U | EnoGene | 25 μg | EUR 541.67 |
|
Description: Available in various conjugation types. |
|||
Alexa Fluor® 700 anti-human CD158e1 (KIR3DL1, NKB1) |
|||
| E16FHI158e-100U | EnoGene | 100 μg | EUR 1105 |
|
Description: Available in various conjugation types. |
|||
 (pORF)) KIR2DL1 ORF Vector (Human) (pORF) |
|||
| ORF005679 | ABM | 1.0 ug DNA | EUR 114 |
 (pORF)) KIR2DL3 ORF Vector (Human) (pORF) |
|||
| ORF005680 | ABM | 1.0 ug DNA | EUR 114 |
 (pORF)) KIR3DL1 ORF Vector (Human) (pORF) |
|||
| ORF005682 | ABM | 1.0 ug DNA | EUR 114 |
 (pORF)) KIR3DL2 ORF Vector (Human) (pORF) |
|||
| ORF013476 | ABM | 1.0 ug DNA | EUR 424.8 |
 (pORF)) KIR2DL2 ORF Vector (Human) (pORF) |
|||
| ORF022276 | ABM | 1.0 ug DNA | Ask for price |
 (pORF)) KIR3DL3 ORF Vector (Human) (pORF) |
|||
| ORF022283 | ABM | 1.0 ug DNA | EUR 486 |
 Antibody) PE-Cy7 anti-human CD158 (KIR2DL1/S1/S3/S5) Antibody |
|||
| E16FHN158-025 | EnoGene | 25 tests | EUR 455 |
|
Description: Available in various conjugation types. |
|||
PE-Cy7 anti-human CD158 (KIR2DL1/S1/S3/S5) Antibody |
|||
| E16FHN158-100 | EnoGene | 100 tests | EUR 1191.67 |
|
Description: Available in various conjugation types. |
|||
) Human KIR2DL3 AssayLite Antibody (RPE Conjugate) |
|||
| 32965-05151 | AssayPro | 150 ug | EUR 513.6 |
) Human KIR2DL3 AssayLite Antibody (APC Conjugate) |
|||
| 32965-05161 | AssayPro | 150 ug | EUR 513.6 |
 (pORF)) KIR2DL5A ORF Vector (Human) (pORF) |
|||
| ORF022277 | ABM | 1.0 ug DNA | Ask for price |
 (pORF)) KIR2DL5B ORF Vector (Human) (pORF) |
|||
| ORF022278 | ABM | 1.0 ug DNA | Ask for price |
 Human KIR2DL1 Protein Lysate 20ug |
|||
| IHUKIR2DL1PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR2DL1 Protein Lysate 20ug |
|||
 Human KIR2DL2 Protein Lysate 20ug |
|||
| IHUKIR2DL2PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR2DL2 Protein Lysate 20ug |
|||
 Human KIR3DL2 Protein Lysate 20ug |
|||
| IHUKIR3DL2PLLY20UG | Innovative research | each | EUR 361 |
|
Description: Human KIR3DL2 Protein Lysate 20ug |
|||
 Human KIR3DL3 Protein Lysate 20ug |
|||
| IHUKIR3DL3PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR3DL3 Protein Lysate 20ug |
|||
) Human KIR2DL3 AssayLite Antibody (FITC Conjugate) |
|||
| 32965-05141 | AssayPro | 150 ug | EUR 513.6 |
 [Fc]) Human KIR2DL3 Protein (His 22-His 245) [Fc] |
|||
| VAng-1858Lsx-100g | Creative Biolabs | 100 µg | EUR 918 |
|
Description: Human KIR2DL3 protein, human IgG1 Fc tag, expressed in human 293 cells. (Uniprot ID: NP_056952) |
|||
Human KIR2DL3 Protein (His 22-His 245) [Fc] |
|||
| VAng-1858Lsx-1mg | Creative Biolabs | 1 mg | EUR 5338.8 |
|
Description: Human KIR2DL3 protein, human IgG1 Fc tag, expressed in human 293 cells. (Uniprot ID: NP_056952) |
|||
 Human KIR2DL5A Protein Lysate 20ug |
|||
| IHUKIR2DL5APLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR2DL5A Protein Lysate 20ug |
|||
 Human KIR2DL5B Protein Lysate 20ug |
|||
| IHUKIR2DL5BPLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human KIR2DL5B Protein Lysate 20ug |
|||
) Human KIR2DL3 AssayLite Antibody (PerCP Conjugate) |
|||
| 32965-05171 | AssayPro | 150 ug | EUR 565.2 |
 [His]) Human KIR2DL3 Protein (His 22-His 245) [His] |
|||
| VAng-1859Lsx-100g | Creative Biolabs | 100 µg | EUR 918 |
|
Description: Human KIR2DL3 protein, His tag, expressed in human 293 cells. (Uniprot ID: NP_056952) |
|||
Human KIR2DL3 Protein (His 22-His 245) [His] |
|||
| VAng-1859Lsx-1mg | Creative Biolabs | 1 mg | EUR 5338.8 |
|
Description: Human KIR2DL3 protein, His tag, expressed in human 293 cells. (Uniprot ID: NP_056952) |
|||
 (OKCD01591)) KIR3DL1 ELISA Kit (Human) (OKCD01591) |
|||
| OKCD01591 | Aviva Systems Biology | 96 Wells | EUR 950.4 |
|
Description: Description of target: Receptor on natural killer (NK) cells for HLA Bw4 allele. Inhibits the activity of NK cells thus preventing cell lysis.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich Immunoassay;Sensitivity: < 0.051 ng/mL |
|||
 (OKEH07603)) KIR2DL3 ELISA Kit (Human) (OKEH07603) |
|||
| OKEH07603 | Aviva Systems Biology | 96 Wells | EUR 1075.2 |
|
Description: Description of target: Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.38ng/mL |
|||
) KIR2DL1 Recombinant Protein (Human) |
|||
| RP017035 | ABM | 100 ug | Ask for price |
) KIR2DL3 Recombinant Protein (Human) |
|||
| RP017038 | ABM | 100 ug | Ask for price |
) KIR3DL1 Recombinant Protein (Human) |
|||
| RP017044 | ABM | 100 ug | Ask for price |
) KIR3DL2 Recombinant Protein (Human) |
|||
| RP040426 | ABM | 100 ug | Ask for price |
) KIR2DL2 Recombinant Protein (Human) |
|||
| RP066825 | ABM | 100 ug | Ask for price |
) KIR3DL3 Recombinant Protein (Human) |
|||
| RP066846 | ABM | 100 ug | Ask for price |
) KIR2DL5A Recombinant Protein (Human) |
|||
| RP066828 | ABM | 100 ug | Ask for price |
) KIR2DL5B Recombinant Protein (Human) |
|||
| RP066831 | ABM | 100 ug | Ask for price |
 Recombinant Human KIR2DL3 Protein, His Tag |
|||
| E40KMH1305 | EnoGene | 20ug | EUR 495 |
 KIR2DL5A / KIR2DL5B Antibody |
|||
| 20-abx323198 | Abbexa |
|
|
KIR2DL5A / KIR2DL5B Antibody |
|||
| 20-abx323213 | Abbexa |
|
|
 KIR2DL5A/KIR2DL5B Antibody |
|||
| 1-CSB-PA944493 | Cusabio |
|
|
|
Description: A polyclonal antibody against KIR2DL5A/KIR2DL5B. Recognizes KIR2DL5A/KIR2DL5B from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000 |
|||
KIR2DL5A/KIR2DL5B Antibody |
|||
| 1-CSB-PA499732 | Cusabio |
|
|
|
Description: A polyclonal antibody against KIR2DL5A/KIR2DL5B. Recognizes KIR2DL5A/KIR2DL5B from Human. This antibody is Unconjugated. Tested in the following application: IHC, ELISA;IHC-p:1:50-300, ELISA:1:10000-20000 |
|||
 (pPM-C-HA)) KIR2DL1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV022715 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-HA)) KIR2DL3 Protein Vector (Human) (pPM-C-HA) |
|||
| PV022719 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-HA)) KIR3DL1 Protein Vector (Human) (pPM-C-HA) |
|||
| PV022727 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-HA)) KIR2DL2 Protein Vector (Human) (pPM-C-HA) |
|||
| PV089104 | ABM | 500 ng | Ask for price |
 (pPM-C-HA)) KIR3DL3 Protein Vector (Human) (pPM-C-HA) |
|||
| PV089132 | ABM | 500 ng | EUR 662.4 |
 (pPM-C-HA)) KIR3DL2 Protein Vector (Human) (pPM-C-HA) |
|||
| PV053903 | ABM | 500 ng | EUR 577.2 |
 (pPB-C-His)) KIR2DL1 Protein Vector (Human) (pPB-C-His) |
|||
| PV022713 | ABM | 500 ng | EUR 394.8 |
 (pPB-N-His)) KIR2DL1 Protein Vector (Human) (pPB-N-His) |
|||
| PV022714 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-His)) KIR2DL1 Protein Vector (Human) (pPM-C-His) |
|||
| PV022716 | ABM | 500 ng | EUR 394.8 |
 (pPB-C-His)) KIR2DL3 Protein Vector (Human) (pPB-C-His) |
|||
| PV022717 | ABM | 500 ng | EUR 394.8 |
 (pPB-N-His)) KIR2DL3 Protein Vector (Human) (pPB-N-His) |
|||
| PV022718 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-His)) KIR2DL3 Protein Vector (Human) (pPM-C-His) |
|||
| PV022720 | ABM | 500 ng | EUR 394.8 |
 (pPB-C-His)) KIR3DL1 Protein Vector (Human) (pPB-C-His) |
|||
| PV022725 | ABM | 500 ng | EUR 394.8 |
 (pPB-N-His)) KIR3DL1 Protein Vector (Human) (pPB-N-His) |
|||
| PV022726 | ABM | 500 ng | EUR 394.8 |
 (pPM-C-His)) KIR3DL1 Protein Vector (Human) (pPM-C-His) |
|||
| PV022728 | ABM | 500 ng | EUR 394.8 |
 (pPB-C-His)) KIR2DL2 Protein Vector (Human) (pPB-C-His) |
|||
| PV089102 | ABM | 500 ng | Ask for price |
 (pPB-N-His)) KIR2DL2 Protein Vector (Human) (pPB-N-His) |
|||
| PV089103 | ABM | 500 ng | Ask for price |
 (pPM-C-His)) KIR2DL2 Protein Vector (Human) (pPM-C-His) |
|||
| PV089105 | ABM | 500 ng | Ask for price |
 (pPM-C-HA)) KIR2DL5A Protein Vector (Human) (pPM-C-HA) |
|||
| PV089108 | ABM | 500 ng | Ask for price |
 (pPM-C-HA)) KIR2DL5B Protein Vector (Human) (pPM-C-HA) |
|||
| PV089112 | ABM | 500 ng | Ask for price |
 (pPB-C-His)) KIR3DL3 Protein Vector (Human) (pPB-C-His) |
|||
| PV089130 | ABM | 500 ng | EUR 662.4 |
 (pPB-N-His)) KIR3DL3 Protein Vector (Human) (pPB-N-His) |
|||
| PV089131 | ABM | 500 ng | EUR 662.4 |
 (pPM-C-His)) KIR3DL3 Protein Vector (Human) (pPM-C-His) |
|||
| PV089133 | ABM | 500 ng | EUR 662.4 |
 (pPB-C-His)) KIR3DL2 Protein Vector (Human) (pPB-C-His) |
|||
| PV053901 | ABM | 500 ng | EUR 577.2 |
 (pPB-N-His)) KIR3DL2 Protein Vector (Human) (pPB-N-His) |
|||
| PV053902 | ABM | 500 ng | EUR 577.2 |
 (pPM-C-His)) KIR3DL2 Protein Vector (Human) (pPM-C-His) |
|||
| PV053904 | ABM | 500 ng | EUR 577.2 |